|Videos|June 29, 2022
Future Perspectives in Renal Cell Carcinoma (RCC)
Author(s)Thomas Hutson, DO, PharmD
Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Keytruda and Padcev for Muscle Invasive Bladder Cancer
2
Giredestrant Shows Benefit for Early Breast Cancer in Phase 3 Trial
3
Patient Advocate Shares Why The Future Is Bright For PV
4
Looking Back on a Blood Cancer Diagnosis Nearly 35 Years Later
5
